EBS

MKT CAP:$438M

Emergent Biosolutions Inc

Market Cap

$438M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NYSE

Healthcare·Drug·🇺🇸·NYSE

Stock Price

$8.07-$4.44 (-35.49%)

Jun 5, 2026

52W High $13.9052W Low $5.63

Company Details

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates throu...

CEO

—

IPO Date

Nov 15, 2006

Website

www.emergentbiosolutions.com

Key Metrics TTM

Revenue

$677M

-29.9% YoY

Net Income

-$9M

EPS (Diluted)

Free Cash Flow

$135M

Revenue / Share

$11.98

Gross Margin

44.4%

Operating Margin

10.5%

Net Margin

-1.3%

FCF Margin

20.0%

P/S

0.6x

P/E

Earnings Reports

Q2 2026

Aug 5, 2026

PENDING

Q1 2026

Apr 30, 2026

$156M-29.7%

FY 2025

Feb 27, 2026

$743M-28.8%

Q4 2025

Feb 27, 2026

$149M-23.6%

Q3 2025

Oct 30, 2025

$231M-21.3%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee